You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

venetoclax

Showing 76 - 100 of 319
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 16, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (8-Chloroadenosine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +6 more
Nov 16, 2022

AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

Not yet recruiting
  • AL Amyloidosis
  • +2 more
  • Venetoclax
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 16, 2022

Chronic Lymphocytic Leukemia, Richter Syndrome Trial in United States (Duvelisib, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Richter Syndrome
  • Miami, Florida
  • +6 more
Jan 6, 2023

Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    Northwestern University
Feb 16, 2023

Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

Recruiting
  • Lymphoma
  • +3 more
  • Venetoclax
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Brasschaat, Belgium
  • +9 more
Jan 19, 2023

Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Venetoclax
  • +4 more
  • Berlin, Germany
  • +9 more
Jan 13, 2023

AML Trial in Aurora (Venetoclax, CC-486)

Recruiting
  • AML
  • Aurora, Colorado
  • +1 more
Apr 4, 2022

Mantle Cell Lymphoma (MCL) Trial in Australia, Canada, United States (Acalabrutinib, Venetoclax, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma (MCL)
  • Duarte, California
  • +11 more
Jul 17, 2023

Chronic Lymphocytic Leukemia Trial (Venetoclax)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Venetoclax
  • (no location specified)
Apr 2, 2022

Acute Myeloid Leukemia Trial in Sacramento (Azacitidine, Uproleselan, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 12, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

Recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +5 more
  • Fresno, California
  • +2 more
Jan 24, 2023

Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Suzhou, Jiangsu, China
  • +1 more
Aug 18, 2022

Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

Completed
  • Leukemia, Lymphocytic, Chronic
  • Dresden, Germany
  • +10 more
Jan 13, 2023

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 20, 2023

Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +8 more
Dec 13, 2022

Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphoblastic
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Jul 19, 2022

Myeloproliferative Tumor Trial in Toronto (Azacitidine, Venetoclax)

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 12, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (Venetoclax, Azacitadine, Vorinostat)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Venetoclax
  • +5 more
  • (no location specified)
Apr 11, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Venetoclax
  • +3 more
  • Chicago, Illinois
  • +2 more
Aug 19, 2022